Cardiff Oncology Stock Investor Sentiment

CRDF Stock  USD 2.61  0.07  2.76%   
Roughly 55% of Cardiff Oncology's stockholders are presently thinking to get in. The analysis of overall sentiment of trading Cardiff Oncology stock suggests that some investors are interested at this time. The current market sentiment, together with Cardiff Oncology's historical and current headlines, can help investors time the market. In addition, many technical investors use Cardiff Oncology stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at thelincolnianonline.com         
Short Interest in Cardiff Oncology, Inc. Drops By 7.8
news
over six months ago at benzinga.com         
Crude Oil Down Over 1 Quoin Pharmaceuticals Shares Spike Higher
benzinga news
over six months ago at finance.yahoo.com         
Cardiff Oncology Full Year 2023 Earnings Beats Expectations
Yahoo News
over six months ago at simplywall.st         
Were Not Very Worried About Cardiff Oncologys Cash Burn Rate
Simply Wall St News at Macroaxis
over six months ago at insidermonkey.com         
Cardiff Oncology, Inc. Q4 2023 Earnings Call Transcript
insidermonkey News
over six months ago at finance.yahoo.com         
Cardiff Oncology, Inc. Q4 2023 Earnings Call Transcript
Yahoo News
over six months ago at thelincolnianonline.com         
Cardiff Oncology Given New 7.00 Price Target at Piper Sandler
news
over six months ago at gurufocus.com         
Cardiff Oncology Inc Reports Q4 and Full Year 2023 Financial Results
Gurufocus Stories at Macroaxis
over six months ago at finance.yahoo.com         
Cardiff Oncology Inc Reports Q4 and Full Year 2023 Financial Results
Yahoo News
over six months ago at benzinga.com         
Small Cap-Cardiff Oncology Outlines Data From Discontinued Colorectal Cancer Trial, Stock Soars
benzinga news
over six months ago at globenewswire.com         
Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
Macroaxis News: globenewswire.com
over six months ago at zacks.com         
Arcellx, Inc. Q4 Earnings and Revenues Surpass Estimates
zacks News
over six months ago at finance.yahoo.com         
Cardiff Oncology Announces First Patient Dosed in Randomized First-line RAS-mutated Metastatic Color...
Yahoo News
over six months ago at finance.yahoo.com         
Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patien...
Yahoo News
over six months ago at seekingalpha.com         
Acquisition by White Lale of 11916 shares of Cardiff Oncology subject to Rule 16b-3
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Cardiff Oncology that are available to investors today. That information is available publicly through Cardiff media outlets and privately through word of mouth or via Cardiff internal channels. However, regardless of the origin, that massive amount of Cardiff data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Cardiff Oncology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cardiff Oncology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cardiff Oncology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cardiff Oncology alpha.

Cardiff Oncology Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Cardiff Stock analysis

When running Cardiff Oncology's price analysis, check to measure Cardiff Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardiff Oncology is operating at the current time. Most of Cardiff Oncology's value examination focuses on studying past and present price action to predict the probability of Cardiff Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardiff Oncology's price. Additionally, you may evaluate how the addition of Cardiff Oncology to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
FinTech Suite
Use AI to screen and filter profitable investment opportunities